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Introduction
EGF is an important chemoattractant in hematogenous metastasis 
of mammary tumors (Wyckoff et al., 2004; Kedrin et al., 2007). 
Upon EGF stimulation, mammary carcinoma cells start to form 
cellular protrusions critical for chemotaxis, such as lamellipodia 
and invadopodia. In carcinoma cells these changes in morphol-
ogy are driven by restructuring of the actin cytoskeletal network 
by several actin-binding proteins (ABPs; Condeelis et al., 2005). 
Cofi  lin, an actin-severing protein, is important for the initial regu-
lation of actin polymerization during EGF stimulation (Mouneimne 
et al., 2004, 2006). Active cofi  lin binds to and severs F-actin, 
thereby increasing the number of free barbed ends (Mouneimne 
et al., 2004). In addition, barbed ends may also be increased by 
the intrinsic nucleation activity of cofi  lin (Andrianantoandro and 
Pollard, 2006). The actin polymerization activity of cofi  lin is con-
sistent with observations that the local activation of cofi  lin causes 
local actin polymerization and cellular protrusions in vivo (Ghosh 
et al., 2004; Mouneimne et al., 2006), which places cofi  lin as a 
key protein in chemotaxis of metastatic cancer cells. Indeed, the 
invasion signature of breast carcinoma cells showed that cofi  lin is 
an important contributor to the metastatic phenotype (Wang et al., 
2004), and recent fi  ndings show that the activity status of cofi  lin 
is directly related to invasion, intravasation, and metastasis of 
mammary tumors (Wang et al., 2006, 2007).
In EGF-stimulated mammary carcinoma cells, the increase 
in cofi  lin-dependent barbed ends occurs in two transients: one at 
1 min, and a late one at 3 min (Mouneimne et al., 2004). The fi  rst 
barbed end transient depends on PLC (Mouneimne et al., 2004), 
but not on PI3K or cofi  lin-dephosphorylation activity (Mouneimne 
et al., 2004; Song et al., 2006), and is required for directional 
sensing during chemotaxis (Mouneimne et al., 2006). However, 
it is not clear how PLC regulates cofi  lin activity. PLC cleaves the 
plasma membrane (PM) phospholipid PIP2 into DAG and IP3. 
Structural and in vitro–binding studies suggest that PIP2 can 
regulate ABPs such as cofi  lin. For example, structural studies 
showed that the putative PIP2-binding sites of many ABPs are 
overlapping with the sites that are important for F-actin binding, 
and therefore lipid binding would prevent actin binding (Yonezawa 
et al., 1990; Ojala et al., 2001; Yin and Janmey, 2003; Gorbatyuk 
et al., 2006). In vitro–binding studies showed that the activity of 
many ABPs is inhibited by PIP2-containing lipid micelles. There-
fore, it has been hypothesized that ABPs bind to and are inhib-
ited by PIP2 in the PM, and upon PLC-mediated PIP2 reduction, 
the ABPs get released and activated (Goldschmidt-Clermont 
et al., 1991, 1992; Janmey and Lindberg, 2004; Di Paolo and De 
Camilli, 2006; Janetopoulos and Devreotes, 2006; Logan and 
EGF-induced PIP2 hydrolysis releases and activates 
coﬁ  lin locally in carcinoma cells
Jacco van Rheenen,
1,4 Xiaoyan Song,
1 Wies van Roosmalen,
1 Michael Cammer,
3 Xiaoming Chen,
1 Vera DesMarais,
1 
Shu-Chin Yip,
2 Jonathan M. Backer,
2 Robert J. Eddy,
1 and John S. Condeelis
1,3,4
1Department of Anatomy and Structural Biology, 
2Department of Molecular Pharmacology, 
3Analytical Imaging Facility, and 
4Gruss Lipper Center for Biophotonics, 
Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461
  L
amellipodial protrusion and directional migration of 
carcinoma cells towards chemoattractants, such as 
epidermal growth factor (EGF), depend upon the spa-
tial and temporal regulation of actin cytoskeleton by actin-
binding proteins (ABPs). It is generally hypothesized that 
the activity of many ABPs are temporally and spatially 
regulated by PIP2; however, this is mainly based on in vitro–
binding and structural studies, and generally in vivo evi-
dence is lacking. Here, we provide the ﬁ  rst in vivo data 
that directly visualize the spatial and temporal regulation 
of coﬁ  lin by PIP2 in living cells. We show that EGF induces 
a rapid loss of PIP2 through PLC activity, resulting in a re-
lease and activation of a membrane-bound pool of coﬁ  lin. 
Upon release, we ﬁ  nd that coﬁ  lin binds to and severs 
F-actin, which is coincident with actin polymerization and 
lamellipod formation. Moreover, our data provide evi-
dence for how PLC is involved in the formation of protru-
sions in breast carcinoma cells during chemotaxis and 
metastasis towards EGF.
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Mandato, 2006). Indeed gelsolin, a G-actin sequestering and 
F-actin capping ABP, is released from membrane fractions when 
PLC is activated (Chen et al., 1996). However, the direct visual-
ization in living cells of the PIP2 hydrolysis and the subsequent 
translocation from the PM and activation of ABPs is generally 
lacking. Here, we have tested this hypothesis in living cells for 
cofi  lin because the EGF-induced activation of cofi  lin is PLC de-
pendent in breast carcinoma cells, and because cofi  lin has been 
proposed to bind to PIP2 in vitro.
In this study, we provide evidence that in mammary carci-
noma cells, cofi  lin is locally activated by release of a membrane-
associated pool of cofi  lin upon EGF-stimulated PIP2 reduction. 
By colocalization, FRET, and membrane fractionation studies, 
we show that a fraction of cofi  lin is membrane associated, 
and that this association is reduced upon decreases in the PIP2 
level. Using FRET- and FLIP-based experiments and a cofi  lin-
severing assay, we show that the released cofi  lin locally binds 
to F-actin and severs actin fi  laments. This is the fi  rst direct 
in vivo demonstration that cofi  lin is regulated by PIP2. Moreover, 
to our knowledge this is the fi  rst report that directly visualizes 
the spatial and temporal regulation of an ABP regulation by 
PIP2 in living cells.
Results
EGF stimulates PLC-dependent PIP2 
reduction in MTLn3 cells
To test whether cofi  lin activity can be regulated by PIP2, we fi  rst 
studied whether changes in the PIP2 level can be induced upon 
EGF stimulation in the rat MTLn3 carcinoma cell line. We have 
chosen this cell type for study because cofi  lin-induced formation 
of barbed ends, cell protrusion, and chemotaxis is PLC dependent 
(Mouneimne et al., 2006), and the metastatic potential of mam-
mary tumors resulting from the growth of these cells is depen-
dent on the activity status of cofi  lin (Wang et al., 2006). To follow 
rapid changes in PIP2 levels in vivo, we used a FRET-based PIP2 
assay that provides high temporal resolution (van der Wal et al., 
2001; van Rheenen and Jalink, 2002; for details see Materials 
and methods and Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200706206/DC1). A fast and signifi  cant drop in 
PIP2-FRET was observed upon EGF stimulation in MTLn3 (14 ± 
5%) and EGFR-overexpressing MTLn3 cells (22 ± 2.5%), 
accompanied by an increase in cell protrusion activity measured 
as an increase in cell area (Fig. 1 A). This observation was con-
firmed by immunofluorescence of fixed MTLn3 cells using 
PIP2-specifi  c antibodies (Fig. S2) before and 1 min after EGF 
stimulation (Fig. 1 A, middle). In resting cells, the antibody 
staining of PIP2 at the PM was higher compared with stimulated 
cells, indicating a decrease of this lipid (Fig. 1 A, right). Analysis 
of the fl  uorescent labeling intensities suggests a drop in the PIP2 
levels of 40 to 60%. Biochemical analysis of low-density mem-
brane fractions showed similar decreases in PIP2 after EGF 
stimulation (see below). These data suggest that the PLC-induced 
increase in cell area may indeed be initiated by PIP2 hydrolysis. 
If so, then inhibition of PLC should block PIP2 hydrolysis and 
subsequently the cell area increase. Mouneimne et al. (2004) 
observed a block in the cell protrusion activity in the fi  rst 3 min 
after EGF exposure in cells treated with the PLC inhibitor U73122, 
but they observed normal protrusion in cells treated with U73343, 
an inactive form of this drug. In line with this, we found that 
EGF-stimulated PIP2 hydrolysis is inhibited by U73122, but 
not by U73343 (Fig. 1, B and C), suggesting that the EGF-
induced increase in protrusion (cell area) is dependent on PLC 
through reduction in PIP2. We have also reduced the level of 
PIP2 by an EGF-independent mechanism. In a recent report, it 
was noted that PIP2 levels can be reduced by cholesterol extrac-
tion with MβCD (Kwik et al., 2003). We observed the same 
phenomenon in our cell type. Both FRET level (33 ± 5%) and 
antibody staining were lower after MβCD treatment, suggesting 
decreased PIP2 levels (Fig. 1 D). Moreover, MβCD treatment 
resulted in an increase in cell area (Fig. 2 A). Although MβCD 
may have many side effects and is therefore a blunt tool to 
reduce PIP2 levels, the observed decrease in PIP2 and the in-
crease in cell area are in line with the idea that PIP2 reduction is 
inducing formation of cellular protrusions.
Co-localization between coﬁ  lin and PIP2 
is diminished upon PLC-dependent PIP2 
reduction
Our model predicts that a fraction of cofi  lin is associated with 
PIP2 in the PM and is inactive, and that upon PIP2 reduction by 
EGF stimulation, this fraction of cofi  lin leaves the PM and be-
comes active. To test this, we studied the spatial distribution of 
cofi  lin before and after PIP2 reduction. In unstimulated cells, a 
fraction of cofi  lin is localized at the periphery of the cell, and is 
closely associated with the PM (Fig. 2 A, left). We hypothesize 
that this is the nonphosphorylated fraction of cofi  lin that is kept 
inactive by PIP2. Upon either EGF stimulation or MβCD treat-
ment, cells form cellular protrusions resulting in the PLC-
  dependent increase in cell area (Fig. 2 A; (Mouneimne et al., 
2004). Cofi  lin is locally released from its peripheral enrichment 
and translocates to the leading edge of the newly formed lamelli-
podia (Fig. 2 A, right). We hypothesize that the cofilin in the 
actin-rich leading edge of lamellipodia is not bound to the 
membrane PIP2 and therefore active. To test our hypothesis, 
we analyzed the immunostaining of PIP2 and cofi  lin at these 
two regions of the cell. First we compared the colocalization of 
PIP2 with the phosphorylated-and nonphosphorylated form of 
cofi  lin. We predict that the spatial relationship between PIP2 and 
membrane-bound cofi  lin should be greater than PIP2 and non-
membrane-bound cofi  lin. The spatial relationship was analyzed 
with scatterplots and Pearson’s correlation coeffi  cient analysis 
of immunofl  uorescence images, and they indeed showed that 
PIP2 has a higher spatial relationship with the membrane-bound 
and nonphosphorylated form of cofi  lin than with the cytosolic 
and phosphorylated form of cofi  lin (Fig. 2, B and C). This sug-
gests that the membrane-bound fraction of cofi  lin is a nonphos-
phorylated form of cofi  lin. To test whether this fraction gets 
released at lower PIP2 levels, cells were stimulated with EGF or 
treated with MβCD (Fig. 1). Changes in PIP2 staining intensity 
do not infl  uence the outcome because Pearson’s correlation co-
effi  cient is insensitive to relative changes in the intensities of the 
two images (Fig. S3, available at http://www.jcb.org/cgi/content/
full/jcb.200706206/DC1). As predicted by our hypothesis that PIP2 HYDROLYSIS ACTIVATES COFILIN • RHEENEN ET AL. 1249
cofi  lin is associated with PIP2 and released as PIP2 levels fall, 
the Pearson’s correlation coeffi  cient indeed drops (Fig. 2 B) 
and the scatterplot shows less spatial correlation (Fig. 2 C), sug-
gesting that PIP2 and cofi  lin become spatially segregated after 
stimulation with EGF or treatment with MβCD. Biochemical 
analysis of membrane fractions by dot blots to detect PIP2 and 
Western blot to detect cofi  lin confi  rmed that cofi  lin is lost from 
the PM in association with a drop in the amount of PIP2 after 
EGF-stimulation or MβCD treatment (Fig. 2, D–F).
If a PLC-dependent drop in the PIP2 level is responsible 
for the translocation of cofi  lin from the PM and the subsequent 
protrusion of the cell, then inhibition of PLC should prevent co-
fi  lin translocation from the PM. In cells treated with U73122, 
but not cells treated with the control drug U73343, EGF neither 
induced a drop in the membrane-associated PIP2 (Fig. 2 E) nor 
a decrease in the PIP2 labeling levels (Fig. 1 C). Interestingly, 
the inhibition of PIP2 hydrolysis was associated with retention 
of membrane-bound cofi  lin (Fig. 2 F) and the inhibition of the 
disruption of colocalization between cofi  lin and PIP2 (Fig. 2, 
B and C). These data strongly suggest that cofi  lin is membrane-
associated and that upon EGF-mediated PIP2 hydrolysis cofi  lin 
gets released from the PM.
Coﬁ  lin leaves the PM upon PLC-dependent 
PIP2 reduction in living cells
To follow the translocation of cofi  lin in living cells, we ex-
pressed a chimera of GFP and cofi  lin in MTLn3 cells. GFP-cofi  lin 
is recognized by GFP and cofi  lin antibodies and the localization 
by GFP is similar to that found by antibody staining (Fig. 3, 
A and B). Translocation of GFP-cofi  lin from the PM was mea-
sured by FRET between GFP-cofi  lin and a membrane-targeted 
mCherry (mCherry-CAAX) (Fig. 3 C). FRET (as measured by 
sensitized emission [sens]) was only observed at the PM (Fig. 3 D; 
for control cells see Fig. S4 A, available at http://www.jcb.org/
cgi/content/full/jcb.200706206/DC1) because mCherry-CAAX 
labeled exclusively the PM and FRET only occurs for molecules 
in close proximity (<10 nm) (Fig. 3 C). FRET (sens) values may 
vary between cells due to (1) variations in expression levels of 
the fl  uorescent proteins (van Rheenen et al., 2005), and (2) dif-
ferent excitation and detection settings (e.g., PMT settings) (van 
Rheenen et al., 2004). However, we compared FRET (sens) values 
in the same cells before and after stimulation, thus the concen-
tration of the probes or the detection sensitivity did not change 
during the experiment and FRET changes can be observed as 
relative changes to the initial FRET (sens) value. Translocation of 
Figure 1.  EGF stimulation induces a rapid loss 
of PIP2 in carcinoma MTLn3 cells. (A) EGF-
  induced decrease in PIP2-FRET (black, average 
23 experiments) and increase in cell area (red) 
were measured in MTLn3 cells overexpressing 
the EGF-receptor (Xue et al., 2006) as described 
in Materials and methods and Fig. S1 (avail-
able at http://www.jcb.org/cgi/content/full/jcb
.200706206/DC1). The middle panel shows 
PIP2-antibodies staining and the quantiﬁ  cation 
before and after EGF (n > 25). (B) MTLn3-EGFR 
cells were treated with the PLC inhibitor U73122 
(n = 16) or the nonactive drug U73343 (n = 9), 
and PIP2 changes were measured by FRET. 
(C) WT MTLn3 cells were treated as described 
in B, and PIP2 levels were analyzed by antibody 
staining. (n > 25) (D) The cholesterol from MTLn3 
cells was extracted by methyl-β-cyclodextrin 
(MβCD). The change in the PIP2 level was moni-
tored by FRET (n =10) and antibody staining. 
Bars, 5 μm. Values were statistically tested by 
t test. *, P < 0.05; **, P < 0.01; error bars 
represent SEM.JCB • VOLUME 179 • NUMBER 6 • 2007  1250
cofi  lin from the PM led to a loss of FRET, and indeed, a rapid 
decrease in cofi  lin FRET (sens) was observed upon EGF stimu-
lation and MβCD treatment (Fig. 3 D and for quantifi  cations, 
Fig. S4 B), which was accompanied by an area increase result-
ing from EGF-stimulated protrusion (Fig. 3 E). GFP-cofi  lin 
translocation is PLC dependent because FRET (sens) decreases 
were not observed in cells treated with U73122 (Fig. 3 D and 
Fig. S4 B). To control for photobleaching (<5%) or the appar-
ent redistribution of the probes during EGF-induced changes in 
cell shape, we divided the sensitized emission by the total 
amount of GFP or mCherry to obtain apparent donor (Ed) and 
acceptor (Ea) FRET effi  ciency. This concentration-independent 
FRET analysis confi  rmed EGF-induced FRET changes (Fig. S4 B) 
excluding any effects of bleaching and redistribution of the 
probe. To test this in more detail, we measured FRET (sens) 
  between mCherry-CAAX and a GFP that was continuously 
tagged to the PM (GFP-CAAX) (Fig. S4 C). As expected, EGF 
stimulation did not result in lower FRET values. These data, 
together with the FRET effi  ciency analysis, exclude that FRET 
(sens) changes observed in Fig. 3, D and E, are a result of 
(1) changes in mCherry-CAAX, (2) changes in cells shape, and 
(3) photobleaching.
Figure 2. PM-associated  coﬁ  lin translocates from the PM upon PLC-dependent PIP2 reduction. (A) MTLn3 cells were stimulated with EGF or treated with 
MβCD. Shown are images of ﬁ  xed cells stained for coﬁ  lin before and after stimulation or treated as indicated (n > 25). The Leica confocal software glow 
lookup table was used for all images. Bars, 10 μm. (B) MTLn3 cells were ﬁ  xed and labeled for PIP2 and for total coﬁ  lin or the phosphorylated form of coﬁ  lin. 
Images were collected before and 1 min after EGF stimulation. The spatial relationship between PIP2 and coﬁ  lin was analyzed with Pearson’s correlation 
coefﬁ  cient analysis (all conditions n > 25). (C) Shown are the merge and the scatterplot images of the coﬁ  lin and PIP2 channels. Scatterplots are from the 
ﬁ  rst 1 μm from the cell edge and were obtained from images that were smoothed ones using ImageJ. The loss in PIP2 signal was compensated by longer 
  exposure times. Note that the higher the spatial relationship between PIP2 and coﬁ  lin, the more pixels in the scatterplot align along the diagonal (n = 8). 
(D) The amount of coﬁ  lin in the low-density membrane fraction was analyzed by Western blot in cells stimulated with EGF or treated with MβCD. Note that 
in contrast to cellular coﬁ  lin (Cell Cof.), pure coﬁ  lin added to the isolation procedure does not localize in these gradient fractions (three independent experi-
ments). The amount of PIP2 in low-density membrane fractions of cells treated with the PLC-inhibitor U73122 or the nonactive form U73343 was analyzed 
by dot blot (E) and the amount of coﬁ  lin in the same fraction was determined by Western blot (F) (three independent experiments). Values were statistically 
tested by t test. *, P < 0.05; **, P < 0.01; error bars represent SEM.PIP2 HYDROLYSIS ACTIVATES COFILIN • RHEENEN ET AL. 1251
To test whether GFP-cofi  lin translocation from the PM 
represents the endogenous cofi  lin translocation, we measured 
FRET between immunostained endogenous cofi  lin (Alexa 488) 
and mCherry-CAAX by acceptor photobleaching experiments. 
As illustrated in Fig. S4, D and E, these experiments indeed sug-
gest that the in vivo–observed translocation of GFP-cofi  lin upon 
EGF represents the translocation of endogenous cofi  lin from the 
PM, and that this translocation is dependent of PLC-mediated 
PIP2 hydrolysis. Collectively, we conclude that cofi  lin leaves the 
PM upon PLC-mediated PIP2 reduction in living cells.
Coﬁ  lin leaves the PM upon 
PLC-independent PIP2 reduction
Collectively, our data suggest that the translocation of cofi  lin 
from the PM is mediated by PLC-dependent reduction in PIP2. 
If so, then the reduction of PIP2 by other means should also 
cause cofi  lin to leave the PM. Rapid loss of PIP2-independent 
PLC can be initiated by a rapamycin-induced recruitment of a 
phosphoinositide 5-phosphatase (5-ptase) enzyme domain to 
the PM (Fig. 4 A; Fig. S5, available at http://www.jcb.org/cgi/
content/full/jcb.200706206/DC1). This translocation is medi-
ated by the heterodimerization of the FRB domain at the PM 
and the FKBP12-tagged 5-ptase domain upon rapamycin expo-
sure (Heo et al., 2006; Varnai et al., 2006). The 5-ptase domain 
dephosphorylates PIP2 into PIP, leading to the loss of PIP2 at the 
PM (Fig. 4 A). In line with our PLC data, rapamycin also in-
duced the translocation of cofi  lin from the PM (Fig. 4 B), con-
firming that this translocation is mediated by a loss in PIP2. 
Moreover, upon rapamycin exposure, we observed the forma-
tion of membrane protrusions, suggesting an activation of cofi  lin 
(Fig. 4 C; Video 1, available at http://www.jcb.org/cgi/ content/
full/jcb.200706206/DC1). As expected, rapamycin-induced 
Figure 3.  Translocation of coﬁ  lin from the PM upon EGF stimulation in living cells. (A) MTLn3 cells were transiently transfected with GFP-coﬁ  lin. GFP-coﬁ  lin 
was detected by Western blot using antibodies against GFP or coﬁ  lin. (B) GFP images were taken from MTLn3 cells expressing GFP-coﬁ  lin before and 
1 min after EGF stimulation. The LCS glow lookup table was used for the images. (C) Schematic representation of FRET between GFP-coﬁ  lin and mCherry-
CAAX. Coﬁ  lin bound to PIP2 is in close proximity to the membrane, and FRET occurs. The distance between the PM and coﬁ  lin will increase upon the trans-
location of coﬁ  lin to cortical F-actin and FRET will diminish. (D) FRET (sens) was measured in nontreated (n = 19) and U73122-treated (n = 16) MTLn3 cells 
expressing GFP-coﬁ  lin and mCherry-CAAX as detailed in the Materials and methods. Shown are FRET images before and after EGF stimulation and before 
and after MβCD treatment. For controls and the quantiﬁ   cation of FRET decreases, see Fig. S4 (available at http://www.jcb.org/cgi/content/full/
jcb.200706206/DC1). (E) FRET signal (black line) and area increase (red line) of MTLn3 cells were measured in time upon EGF stimulation on the confocal 
microscope at 25°C. Plotted is the average of seven experiments. Bars, 5 μm.JCB • VOLUME 179 • NUMBER 6 • 2007  1252
membrane protrusions are not inhibited by the PLC inhibitor 
U73122 (Fig. 4 C).
From all this, we conclude that cofi  lin translocates from 
the PM upon rapamycin-induced PIP2 reduction, and that this 
leads to the formation of membrane protrusions.
Coﬁ  lin released from the PM is active
Our model predicts that the translocation of the spatially con-
fi  ned and membrane-associated cofi  lin (Fig. 2 A, the xz projec-
tion) will lead to a local increase in activity. Active cofi  lin binds 
to and severs F-actin (Wang et al., 2007). To test whether cofi  lin 
activity increases upon PLC-mediated PIP2 reduction, we mea-
sured cofi  lin binding to F-actin by FRET. MTLn3 cells were 
fi  xed using a method that retains F-actin but loses G-actin (Song 
et al., 2006) and immunostained for endogenous cofi  lin (donor: 
Alexa 488) and F-actin (acceptor: rhodamine), and FRET was 
measured by acceptor photobleaching experiments. If cofi  lin is 
membrane bound, the distance between cofi  lin and F-actin is 
large, resulting in low FRET values. If cofi  lin is bound to F-actin, 
these molecules are in close proximity and FRET will be 
high in a relatively non-diffusible location. Cofi  lin/actin FRET 
increased upon EGF stimulation or MβCD-treatment, indicat-
ing that cofi  lin binds to actin fi  laments within 60 s after EGF 
stimulation (Fig. 5 A). Interestingly, cofi  lin–actin fi  lament bind-
ing is reduced if PLC is inhibited, showing that the cofi  lin that 
binds to F-actin originates from the PM (Fig. 5 A). Strikingly, 
localized application of EGF by a micropipette resulted in a 
localized increase in FRET, where FRET values were two times 
Figure 4.  5-ptase induced reduction of PIP2 leads to coﬁ  lin translocation from the PM. MTLn3 cells were transfected with an mRFP-tagged 5-ptase and a 
PM-targeted CFP-FRB domain. Upon rapamycin addition, the 5-ptase translocated to the PM (for explanation see Fig S5 and Varnai et al. [2006]). PIP2 lev-
els were followed by YFP-PH(PLCδ1) (A), and the coﬁ  lin membrane localization was followed by GFP-coﬁ  lin (B). Below the images, the intensity proﬁ  les of 
FRB, PH, and 5-ptase ﬂ  uoresence through the cell are shown. The blue lines represent pre and the red lines represent post-rapamycin (n > 15). Bars, 5 μm. 
(C) The formation of lamellipodia upon rapamycin (t = 0) addition was followed by confocal microscopy (see also Video 1, available at http://www.jcb
.org/cgi/content/full/jcb.200706206/DC1). Shown are the images of PM-targeted CFP-FRB domains, before (t = 0) or 21 s (t = 21) after rapamycin 
  addition. The right image represent a merge of binary threshold images (ImageJ) of image t = 0 and t = 21. Yellow represents no change, red represents 
increase lamellipod formation. The bottom images show the kymograph of the formation of the lamellipod, and the area of the cell that was used for the 
kymograph. From the kymographs, the size of the lamellipod was measured and plotted against time (right panel) for nonstimulated cells (control, red 
dashed line), rapamycin-stimulated cells (rapa, red line), and for cells that were treated with U73122 and stimulated with rapamycin (U73122 + rapa, 
blue line) and for cells that were treated with U73122 only (U73122 control, blue dashed line). n = 12; error bars represent SEM.PIP2 HYDROLYSIS ACTIVATES COFILIN • RHEENEN ET AL. 1253
higher at the front of the cell close to the pipette than at the 
  opposite side of the cell (Fig. 5 B). This strongly suggests that 
localized EGF application results in a local translocation of cofi  lin 
from the PM to F-actin.
Coﬁ  lin switches from PM binding 
to F-actin binding
To investigate the switch between PM and actin fi  lament binding 
by cofi  lin after EGF stimulation, we performed fl  uorescence 
loss in photobleaching (FLIP) experiments. GFP-cofi  lin stains 
the periphery and cytosol. With an intense laser, a region in the 
cytosol was bleached, and we measured the fl  uorescence inten-
sity at the periphery (Per), and in the cytosol (Cyt) over time 
(Fig. 6 A). Because cofi  lin molecules localized at the periphery 
are retained at the PM or on actin fi  laments, those molecules will 
be bleached less effi  ciently compared with the free diffusible cyto-
solic cofi  lin molecules, leading to an increase in the ratio of 
Per/Cyt staining (Fig. 6 A, right graph). The residence time of 
cofi  lin on actin fi  laments or the PM determines how fast the Per/
Cyt ratio returns to baseline. If the actin fi  lament and PM resi-
dence times are different, a change in the ratio of PM/actin bind-
ing will lead to a change in the overall residence time of cofi  lin 
at the periphery, and thus also the recovery time. Photobleaching 
during image acquisition or fl  uctuations in the laser power will 
equally infl  uence the fl  uorescence loss of the periphery and the 
fl  uorescence increase in the cytosol, and therefore do not infl  u-
ence the outcome. To test the dynamic range of our FLIP experi-
ment, a freely diffusible GFP and a PM-tagged GFP (coexpressed 
with free diffusible GFP as cytosolic marker) were tested. As can 
be seen in Fig. 6 B, free diffusible GFP recovers very fast, whereas 
the recovery of PM-tagged GFP recovers very slowly. To test 
whether cell shape changes infl  uence the recovery rate caused by 
a change in PM background bleaching, the cells were stimulated 
with EGF. As shown in Fig. 6 B, this does not infl  uence the 
recovery of PM-tagged GFP, excluding cell shape effects on 
recovery rates. The same experiments were performed for GFP-
cofi  lin. In unstimulated cells, GFP-cofi  lin recovers rapidly, whereas 
in EGF-stimulated cells, the recovery is much slower. Inhibition 
of PLC by U73122 generates recovery rates for GFP-cofi  lin 
equal to the unstimulated rate (Fig. 6 C). We fi  tted the cofi  lin data 
with two component exponential decays representing the PM and 
actin binding, with a fast component of 3.7 and a slow component 
of 26 s. Unstimulated cells contain predominately the fast 
fraction (85%), whereas the stimulated cells contain predominately 
the slow fraction (62%) (Fig. 6 D). Because FRET experiments 
of cofilin-PM and cofilin-actin filaments showed that cofilin 
in unstimulated cells is predominately bound to the PM, and in 
EGF-stimulated cells predominately bound to F-actin, it is very 
Figure 5. Coﬁ  lin binds actin upon PLC-mediated PIP2 reduction. (A) Control or EGF-stimulated MTLn3 cells were ﬁ  xed and labeled for coﬁ  lin (donor; Alexa 
488) and F-actin (acceptor; rhodamine). Using a high laser power, a region was bleached in the acceptor ﬂ  uorescence (white square box). The increase 
in the donor ﬂ  uorescence was measured and FRET was calculated for un-treated, U73122-treated, or MβCD-treated cells (right panel; for all n > 15). 
(B) FRET was measured in a cell that was stimulated by local application of EGF using a pipette (asterisk). In the graph we plotted the normalized FRET values 
at the side of the cell close to the pipette (front) and the opposite side of the cell (back) (n = 5). Values were statistically tested by t test. *, P < 0.05; **, 
P < 0.01; error bars represent SEM.JCB • VOLUME 179 • NUMBER 6 • 2007  1254
likely that the fast component is membrane-bound cofi  lin, while 
the slow component is the F-actin–bound cofi  lin. This means 
that in unstimulated cells, 85% of cofi  lin molecules located at 
the periphery is PM bound, which goes down to 38% upon EGF 
stimulation, except in PLC-inhibited cells (Fig. 6 D). The actin 
fraction is 15% in unstimulated cells, which increases to 62% 
after EGF stimulation, which is blocked when PLC is inhibited 
(Fig. 6 D). Thus, our FLIP data are consistent with the interpre-
tation that upon EGF stimulation, cofi  lin translocates from the 
PM to underlying F-actin.
To investigate the activation state of cofi  lin during the time 
it is being released from the PM, we measured activity of cofi  lin 
in cell lysates prepared from cells either before or after EGF 
stimulation, and then using a cofi  lin-severing assay to measure 
cofi  lin activity in the cell lysate. Indeed, PIP2 reduction either 
induced by EGF-stimulation or MβCD treatment (Fig. 1) leads 
to an increase in the severing activity of cofi  lin (Fig. 6 E). 
Importantly, the PLC inhibitor U13122 potently inhibits the 
EGF-induced increase of cofi  lin-severing activity (Fig. 6 E), show-
ing that this increased severing activity is dependent on PIP2 
reduction and cofi  lin translocation from the PM to F-actin.
Discussion
PLC activity is required for EGF-induced actin polymerization 
and cell motility of mammary carcinoma cells (Chen et al., 
1994; Mouneimne et al., 2004, 2006); however, the molecular 
basis of how PLC regulates actin dynamics and motility is not 
well established. The data presented in this manuscript explain 
how PLC affects the activity of a PM-associated fraction of 
Figure 6. Coﬁ  lin translocates from the PM to 
F-actin upon PLC-mediated PIP2 reduction. (A) 
The membrane and actin binding of GFP-coﬁ  lin 
was followed by FLIP experiments on the con-
focal microscope at 25°C. At time 0, the cy-
tosolic GFP-coﬁ  lin was bleached brieﬂ  y (bleach 
region indicated in yellow) and the ﬂ  uores-
cence at the cell periphery (Per in blue) and 
the cytosol (Cyt in red) were followed over 
time (middle graph). Upon bleaching, the 
Per/Cyt ratio increases, and because of ex-
change of molecules in the Cyt and Per, the 
ratio decreases to baseline. To normalize for 
bleach efﬁ  ciencies, the initial ratio was set to 0 
and the ﬁ  rst point after bleaching was set to 1. 
(B) Experiments as described in A for cells 
expressing GFP and GFP-CAAX, and cells 
expressing GFP. The dark green and pink 
lines represent the GFP-CAAX/GFP experi-
ments in unstimulated and EGF stimulated 
cells, respectively. The light green line repre-
sents the GFP experiment. Note that EGF-
  induced cell shape changes did not inﬂ  uence 
the GFP-CAAX/GFP FLIP, and therefore did 
not inﬂ  uence the GFP-coﬁ  lin FLIP results (for 
all n > 15). (C) Experiments as described in 
B for cells expressing GFP-coﬁ   lin. The blue 
and red squares represent unstimulated and 
EGF-stimulated (1 min) cells, respectively. The 
pink squares represent EGF-stimulated (1 min) 
U73122-treated cells. Black lines are the two 
component exponential decays ﬁ  ts with taus 
of 3.7 and 26 s (for both n > 15). (D) The 
fractions of the fast and slow taus before and 
after EGF (for 1 min) stimulation in U3122-
treated or untreated cells (all n > 15). (E) Co-
ﬁ  lin activity in untreated, 5 min MβCD-treated, 
1 min EGF-stimulated, or EGF-stimulated and 
U73122-treated cells. Coﬁ   lin activity was 
standardized over total protein content and 
normalized to untreated cells. (average of three 
independent experiments). Bars, 5 μm. Values 
were statistically tested by t test. *, P < 0.05; 
**, P < 0.01; error bars represent SEM.PIP2 HYDROLYSIS ACTIVATES COFILIN • RHEENEN ET AL. 1255
 cofi  lin, resulting in changes in actin polymerization and protru-
sion. The invasion signature of breast carcinoma cells has shown 
that cofi  lin is an important contributor to the metastatic pheno-
type (Wang et al., 2004, 2007), and recent fi  ndings show that the 
activity status of cofi  lin is directly related to the invasion, in-
travasation, and metastasis of mammary tumors (Mouneimne 
et al., 2006; Wang et al., 2006, 2007). The initial cofi  lin activation 
after EGF stimulation in metastatic tumor cells is independent 
of PI3K and cofi  lin dephosphorylation (Mouneimne et al., 2004; 
Song et al., 2006). Here, we provide evidence for the require-
ment of PLC during the initial activation of cofi  lin and provide 
the mechanism by which this occurs during EGF-mediated pro-
trusion formation and metastasis. It is important to note that the 
mechanism described in this paper applies to metastatic amoe-
boid tumor cells in which migration is PLC dependent and co-
fi  lin dependent (Wang et al., 2007). In this cell type, the initial 
activation of cofi  lin upon EGF stimulation is uncoupled from its 
phosphorylation status, and therefore the activation of cofi  lin is 
highly dependent on PLC. However, it has been shown recently 
in less metastatic mesenchymal-type tumor cells that the pheno-
type of cofi  lin suppression is different, suggesting that cofi  lin 
may be regulated by alternate pathways which may be cell-type 
dependent (Sidani et al., 2007; Wang et al., 2007). Therefore, in 
some cell types, the activation may be more dependent on the 
dephosphorylation of cofi  lin by phosphatase such as slingshot, 
while the PLC-mediated pathway plays a less prominent role 
(Nishita et al., 2005; Soosairajah et al., 2005). This supports the 
idea that both mechanisms are physiologically important, but the 
contribution of either of the signaling pathways may differ in 
different cell types and under various conditions.
In this manuscript, we tested the hypothesis that a pool of 
cofi  lin is associated with and inhibited by PIP2 in the PM, and 
that it can be released and activated upon PLC-mediated PIP2 
hydrolysis. Using biochemical, FRET, and FLIP experiments, 
we identifi  ed three cofi  lin compartments in the cell—the cyto-
solic, PM-associated, and F-actin–bound compartments—the 
latter two at the periphery of the cell. FLIP experiments showed 
that cofi  lin can rapidly cycle between these compartments and 
that upon EGF stimulation, cofi  lin molecules at the PM com-
partment translocate to the F-actin compartment. These obser-
vations suggest the activity cycle shown in Fig. 7. In unstimulated 
cells, cofi  lin at the cell periphery is mainly localized in the PM 
compartment. Upon EGF-induced PIP2 reduction, this pool is 
released from the PM and translocates to the nearby F-actin 
compartment. The increase in the number of cofi  lin molecules 
that bind to actin fi  laments leads to actin severing, which in turn 
leads to an increase in free barbed ends and cofilin–G-actin 
products. The cofilin–G-actin product is not able to bind to 
F-actin or the PM, and therefore diffuses to the cytosol compart-
ment. Cofi  lin is released from the cofi  lin–G-actin complex by 
phosphorylation in order to reenter the PM or F-actin compart-
ments. The result of releasing cofi  lin from the PM is an increase 
in the number of barbed ends in the F-actin compartment fol-
lowed by the elongation of fi  laments by polymerization from the 
barbed ends of the severed fi  laments. The newly polymerized 
actin fi  laments are preferred by the ARP2/3 complex for binding 
(Ichetovkin et al., 2002). Each ARP2/3 complex nucleates a new 
daughter branch from the side of the cofi  lin-generated mother 
fi  lament, resulting in a large amplifi  cation of actin polymeriza-
tion resulting from cofi  lin activity. This actin polymerization is 
the driving force for the formation of membrane protrusions.
In line with our model, we observed that rapamycin-
induced PIP2 reduction leads to translocation of cofi  lin from the 
membrane with the subsequent formation of membrane protru-
sions. In contrast to EGF stimulation, the protrusions caused by 
rapamycin-induced PIP2 reduction are small and do not persist. 
This is consistent with recent work showing (1) that EGF-induced 
lamellipod extension requires both cofi  lin and ARP2/3, which 
cooperate and act synergistically in driving dendritic nucleation 
and membrane extension (Ichetovkin et al., 2002; DesMarais 
et al., 2004); and (2) that acute loss of PIP2 induced by rapamy-
cin leads to loss of ARP2/3 subunits from lamellipods (Zoncu 
et al., 2007). Contrastingly, EGF stimulation leads to cofi  lin 
activation without negatively affecting ARP2/3 localization 
(DesMarais et al., 2004). Therefore, in the case of EGF stimula-
tion, cofi  lin and ARP2/3 are activated together, resulting in the 
formation of stable and large protrusions. In the case of rapamy-
cin, the initial cofi  lin-induced actin polymerization is not amplifi  ed 
by ARP2/3, leading to the formation of small protrusions with 
a subsequent collapse. These results suggest that rapamycin-
induced PIP2 reduction that leads to depletion of ARP2/3 can 
lead to lamellipod collapse (Zoncu et al., 2007), and our results 
suggest that the extent of collapse can be counteracted by the 
activation of cofi  lin.
As illustrated in Fig. 7, our data demonstrated that cofi  lin 
molecules at the PM compartment are released and activated by 
decreases in the PIP2 level induced by PLC or a 5-ptase. Whether 
cofi  lin at the PM compartment is inactive through direct PIP2 
binding or indirectly through an adaptor molecule cannot be 
concluded from our data. For example, we cannot exclude the 
possibility that cofi  lin interacts with a protein at the PM, result-
ing in cooperative PM binding and cofi  lin inactivation. Cooper-
ative binding may lead to a higher apparent affi  nity for the PM 
than expected from in vitro–binding affi  nities (McLaughlin 
et al., 2002) and the strong selectivity of PM association for the 
dephosphorylated form of cofi  lin, which is not predicted from 
structural studies (Gorbatyuk et al., 2006). A reduction of PIP2 
in the PM may lead to a direct reduction of cofi  lin–PIP2 binding, 
or in the case of cooperative binding, it may lead to a reduced 
cofi  lin adaptor protein binding or adaptor protein PIP2 binding. 
Although we cannot exclude cooperative binding, existing bio-
chemical data point toward direct binding of cofi  lin to PIP2 because 
cofi  lin binds specifi  cally to PIP2 in PIP-strips (unpublished data), 
and cofi  lin activity in vitro is inhibited by micelles containing 
PIP2 (Yonezawa et al., 1990, 1991; Ojala et al., 2001). Although 
the binding mechanisms in both models may differ, the output 
is the same: PIP2 reduction leads to the release from the PM and a 
local activation of cofi  lin.
In polarized cells, the activation of cofi  lin is restricted to-
ward the chemoattractant source achieved by a local excitation 
global inhibition (LEGI) mechanism (Mouneimne et al., 2006). 
This LEGI mechanism involves the global phosphorylation of 
cofi  lin in the cytosol compartment by LIMK in response to EGF 
stimulation in breast carcinoma cells in concert with cofi  lin’s JCB • VOLUME 179 • NUMBER 6 • 2007  1256
local activation by PLC at the PM and its translocation to the 
F-actin compartment (Fig. 7). The rapid phosphorylation of co-
fi  lin close to the actin compartment acts to sharpen the spatial 
location of cofi  lin activation. Therefore, the local activation of 
cofi  lin by PLC as shown in this study is the key to the initiation 
of local actin polymerization required for chemotaxis, as postu-
lated previously (Mouneimne et al., 2006; Song et al., 2006).
It has been widely hypothesized that the activities of vari-
ous ABPs such as gelsolin, profi  lin, capping protein, and cofi  lin 
are modulated by phospholipid binding (Janmey and Lindberg, 
2004; Di Paolo and De Camilli, 2006; Janetopoulos and 
Devreotes, 2006; Logan and Mandato, 2006). However, this hy-
pothesis is mainly based on structural and in vitro–binding studies. 
Here, we provide compelling in vivo evidence demonstrating the 
activation of an ABP, cofi  lin, by varying a phospholipid, PIP2. 
Furthermore, we have demonstrated that the activation of cofi  lin 
by PLC-induced changes in PIP2 levels causes a translocation 
of cofi  lin from the PM compartment to the F-actin compart-
ment, suggesting a mechanism for how the activities of other 
PIP2-regulated ABPs may be localized in cells.
Materials and methods
Cell culture
MTLn3 (rat mammary adenocarcinoma cell line) cells were maintained, 
starved as described previously (Song et al., 2006). For light microscopy 
experiments, MTLn3 cells were plated on glass-bottom dishes (MatTek 
  Corporation) that had been treated with HCl and ethanol and washed 
with PBS. For PIP2 FRET experiments, the dishes were coated with poly-L-
lysine (Sigma-Aldrich) and collagen. Before the experiments, cells were 
starved in L15 medium (Invitrogen) supplemented with 0.35% BSA for 2.5 
to 4 h. A bath application of 5 to 15 nM EGF (Invitrogen) for 1 min or 
5 mM methyl-β-cyclodextrin (MβCD) for 2.5 min was used to stimulate 
the cells.
DNA constructs and transfections
The pNA3 expression vectors with inserts eCFP-PH(PLCδ1), and GFP-CAAX 
were a gift of K. Jalink (Netherlands Cancer Institute, Amsterdam, The 
Netherlands). PM-FRB-CFP and mRFP-FKBP-5-ptase domain were a gift 
of T. Balla (National Institute of Child Health and Human Development, 
NIH, Bethesda, MD). pEYFP-Mem was from Clonetech Laboratories, Inc. 
pcDNA3 with the insert of mCherry-CAAX was obtained by replacing GFP 
of pcDNA3-GFP-CAAX with mCherry using the BamHI and EcoRI restriction 
sites. GFP-coﬁ  lin was constructed by subcloning the rat coﬁ  lin from peGFP-
N1-coﬁ  lin (described in DesMarais et al. [2004]) into pEGFP-C1 with 
HindIII. A frame shift was corrected by removing the overhang of SacI by 
T4 polymerase. Constructs were transfected using Lipofectamine 2000 
Figure 7.  Compartments involved in the coﬁ  lin activity cycle. Coﬁ  lin molecules cycle through three compartments in the cell; the cytosol, the actin, and 
the PM compartments. Coﬁ  lin at the PM compartment initially translocates to the F-actin compartment upon EGF mediated PIP2 reduction. Coﬁ  lin binds 
and severs actin ﬁ  laments resulting in ﬁ  laments with free barbed ends, and coﬁ  lin–G-actin complex. The coﬁ  lin–G-actin complex cannot bind actin 
or PM, and therefore diffuses to the cytosol compartment. In the cytosol compartment, coﬁ  lin is phosphorylated by LIM-kinase, resulting in the release 
of coﬁ  lin from the coﬁ  lin–G-actin complex. Upon coﬁ  lin dephosphorylation by SSH, coﬁ  lin can reenter the PM or F-actin compartment, starting a 
new   cycle. The cycling of coﬁ  lin through the three compartments increases free barbed ends, resulting in newly polymerized actin ﬁ  laments. 
The ARP2/3 complex prefers to bind to these newly formed actin ﬁ  laments, which ampliﬁ  es the coﬁ  lin-induced actin polymerization, resulting in protru-
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(Invitrogen) at 1μg DNA per MatTek dish. After transfection, the cells were 
washed with fresh medium and incubated until use.
Immunoﬂ  uorescence
MTLn3 cells were ﬁ  xed and permeabilized as previously described (Song 
et al., 2006). In brief, cells were simultaneously ﬁ  xed and extracted using 
3.7% paraformaldehyde, 0.1% glutaraldehyde (Electron Microscopy 
Sciences), and 0.075% mg/ml saponin (Sigma-Aldrich) in PBS. Compared 
with sequential ﬁ  xation and detergent extraction protocols, simultaneous 
ﬁ  xation and extraction results in depletion of soluble G-actin (Song et al., 
2006). Primary antibodies diluted in blocking buffer were incubated with the 
ﬁ  xed cells for 1 h. Secondary antibodies (AlexaFluor 488 or 555; Molecular 
Probes) were diluted in blocking buffer and incubated with the cells for 1 h. 
Cells were washed and mounted in PBS.
FRET-based PIP2 hydrolysis assay
Kinetic analysis of PIP2 hydrolysis by FRET was assayed as described (van 
der Wal et al., 2001) with some modiﬁ  cations. Cells were placed on an 
inverted microscope (model 470; Olympus) equipped with Zeiss EC Plan-
NeoFluar 40×/1.3 OIL PH3 objective, a computer-driven cooled CCD 
camera, humidiﬁ  ed CO2 chamber, and were kept at 37°C. Excitation was 
done with a Lambda DG-4 using a D430/25 CFP excitation ﬁ  lter, and 
IPLab Spectrum software (VayTek) was used to collect images. A ND2 ﬁ  lter 
was used in the excitation path to minimize photo toxicity during long 
experiments. A dual-band dichroic mirror 86002v2bs was used (Chroma 
Technology Corp.), and emission was collected on a dual-view 505 dcxr 
D465/30m (CFP) HQ535/30m (YFP) (Optical Insights, LLC). Images were 
collected every 3 s and stored on the computer. Using a custom-made 
Visual Basic (vb6.0) program, the images were imported and analyzed. 
Following a threshold step, background regions were determined and the 
background was measured and subtracted from the images. Cells were 
traced with a ﬁ  xed threshold and the mean ﬂ  uorescence level of CFP and 
YFP of the whole cells was measured. CFP leak-through was subtracted 
from the YFP values (leak-through factor was 0.84 and was established 
in cells expressing only CFP) and the YFP value was multiplied by a ﬁ  xed 
factor which was determined at the onset of the experiment to achieve a 
YFP/CFP ratio of 1. FRET changes were measured as an offset of the initial 
value. For more details see Fig. S1.
Antibody-based PIP2 assay
PIP2 antibody was purchased from Assay Designs, Inc. Pictures were taken 
using 60× NA1.4 inﬁ  nity-corrected optics on a microscope (model IX170; 
Olympus) supplemented with a computer-driven cooled CCD camera. IPLab 
Spectrum software (VayTek) was used to collect images, and exposure times 
were kept constant. Digital images were linearly converted in NIH ImageJ 
and analyzed using a customized macro. The macro averages the ﬂ  uores-
cence intensity in 29 annuli, ranging from 1.1 μm outside the cell periph-
ery and extending approximate 6 μm inside the cell (consecutive annuli 
are 0.22 μm apart from each other). The averaged ﬂ  uorescence intensity 
of the ﬁ  rst 1 μm inside the cell was used to represent the membrane PIP2 
changes. For every condition, at least 30 cells were analyzed.
Membrane fractionation
A 100-mm plate of MTLn3 cells at  90% conﬂ  uence was lysed with 100 μl 
of ice-cold lysis buffer (50 mM Tris, pH 7.5, 300 mM NaCl, 5 mM 
EGTA, 20 mM DTT, 2% Triton X-100, 1× protease inhibitor mixture, and 
50 mM NaF). Cell lysates were collected after incubating the lysates on ice 
for 30 min. The harvested cell lysate was mixed with 60% OptiPrep (AXIS-
SHIELD PoC AS) to yield 40% OptiPrep ﬁ  nal. The lysate containing 40% 
OptiPrep was transferred to the bottom of a centrifuge tube. 1 ml 30% Opti-
Prep was added carefully on top of 40% OptiPrep lysate to avoid disrupt-
ing the interface. 300 μl of 5% OptiPrep was added carefully on top of 
30% OptiPrep. Tubes were centrifuged for 12–14 h at 4°C in a rotor at 
100,000 g (TLS55; Beckman Coulter). Gradient fractions (150 μl) were 
collected and coﬁ  lin content was analyzed by immunoblotting. To analyze 
the amount of PIP2, 1 μl of each gradient fraction was dot blotted onto nitro-
cellulose and dried for 1 h. Dot blot was then probed with a monoclonal 
antibody raised against PI(4,5)P2 (Assay Designs). Densitometry analysis 
was done in ImageJ (W.S. Rasband, NIH, Bethesda, MD; http://rsb.info
.nih.gov/ij/). The amount of coﬁ  lin or PIP2 in the low-density fraction was 
normalized against the total amount of coﬁ  lin in the lysate.
Coﬁ  lin activity assay
The relative coﬁ  lin-severing activity was quantiﬁ  ed using a slightly modiﬁ  ed 
version of the established microscopy severing assay (Chan et al., 2000; 
Ichetovkin et al., 2000). In brief, MTLn3 cell lysates were prepared by lysing 
cells (3 × 10
7 cells/ml) in lysis buffer at different times after EGF stimu-
lation. Rhodamine- and biotin-labeled F-actin were prepared by incubating 
0.4 μM rhodamine-labeled actin, 0.2 μM biotin-labeled actin, and 1.4 μM 
unlabeled actin in polymerization buffer and 0.2 μM phalloidin for no 
more than 1.5 h at room temperature. A ﬂ  ow chamber precoated with 
0.5% nitrocellulose in amylacetate was perfused in biotin antibody for 
5 min. Rhodamine/biotin-labeled F-actin was diluted 30 times to perfuse in 
the ﬂ  ow chamber. The severing of actin ﬁ  laments by cell lysates prepared 
from MTLn3 cells was observed under a TIRF microscope. Due to the cross-
linking of ﬁ  laments to the solid surface, the ﬁ  laments are stable indeﬁ  nitely, 
and 20 min was used routinely as the control check time to see if any ﬁ  la-
ment severing occurred in the absence of coﬁ  lin. Filament numbers were 
quantiﬁ  ed in ImageJ. The relative coﬁ  lin activity was measured by dividing 
the number of ﬁ  laments 5–10 min after adding the lysates by the number 
of ﬁ  laments before adding cell lysates in the same ﬁ  eld. Confocal experi-
ments using function-blocking coﬁ  lin antibodies were done to conﬁ  rm that 
all severing activity was due to coﬁ  lin.
Sensitized emission
Sensitized emission was calculated from confocal GFP and mCherry im-
ages using a highly corrected algorithm as recently described (van Rheenen 
et al., 2004), in a custom-made Visual Basic program. In short, three im-
ages were collected with a confocal microscope (TCS SP2 AOBS; Leica) 
with 60× oil immersion optics at 25°C; a GFP image excited at 488 nm 
(
488nmGFP), a mCherry image excited at 488 nm (
488nmmCherry), and a 
mCherry image excited at 560 nm (
560nmmCherry). Upon background sub-
traction, sensitized emission (FRET(sens)) was calculated as follows:
FRET(sens) = (
488nmmCherry − β
488nmGFP − (γ − αβ)
560nmmCherry)/(1 − βδ),
where α is the correction factor for mCherry ﬂ  uorescence excitation at 
488 nm and detected in the 
488nmGFP channel, β is the leakthrough of GFP 
in the 
488nmmCherry channel, δ that for leak-through of sensitized emission 
back into the 
488nmGFP channel, and γ relates mCherry ﬂ  uorescence de-
tected in the 
488nmGFP channel to the mCherry ﬂ  uorescence detected in the 
488nmmCherry channel. The α, β, γ, and δ correction factors were deter-
mined on-line from cells expressing either GFP or mCherry ﬂ  uorescence 
proteins alone, present on the same coverslip (for more details see van 
Rheenen et al., 2004). For each image, the correction factors were rede-
termined to correct for laser ﬂ   uctuations. Apparent FRET efﬁ   ciencies 
(Ed and Ea) were obtained by relating FRET (sens) to the GFP or mCherry 
image, respectively. To compare independent measurements of Ea, Ea was 
divided by the γ factor (van Rheenen et al., 2004). Regions of interest such 
as the PM were determined by a threshold step in the mCherry image. 
FRET values were calculated by applying the same algorithms on the raw 
mean data of the region of interest.
Acceptor photobleaching experiments
Donor and acceptor confocal images were collected before and after photo-
bleaching of the acceptor. In a custom-made Visual Basic program, the 
post-bleached donor image was corrected for imaging-bleaching and the 
gain in donor and the loss in acceptor ﬂ  uorescence were determined at 
the cell periphery. FRET was calculated by relating the gain of donor ﬂ  uores-
cence to the total amount post-bleach acceptor ﬂ  uorescence. All FRET cal-
culations were performed on the mean values of regions of interest of the 
periphery of the cell. No signiﬁ  cant photo conversion of the acceptor was 
observed during photobleaching.
Colocalization analysis
Colocalization analyses were performed on the ﬁ  rst 1 μm of a cell. Cells 
were precisely traced on phase-contrast images. Pixels along the perimeter 
were measured for intensity correlation. The perimeter was inset by one 
pixel and measured. This was repeated iteratively to provide Pearson’s co-
efﬁ  cient from the outer edge of the cell toward the center at 0.22-μm 
steps for the ﬁ  rst 1 μm of the cell. Pearson’s correlation coefﬁ  cients (r) were 
calculated as previously described (Song et al., 2006) using the follow-
ing equation:
r = (ΣXY − (ΣXY/N))/((ΣX
2 − (ΣX
2/N)) × ((ΣY
2 − (ΣY
2/N))) 
0.5,
where element X was a pixel value of one probe, and Y the corresponding 
pixel value of the other probe at the same spatial location, and N the num-
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For scatterplot analyses, the ﬁ  rst 1 μm of the cell was precisely 
traced on the ﬂ  uorescent images and the analysis was performed in a cus-
tom-made Visual Basic program, where the pixel intensity of the ﬁ  rst image 
(image A) was plotted against the pixel intensity of the second image 
  (image B). However, because of small misalignments in ﬁ  lter sets, the image of 
the second probe (image B) can have a pixel shift relative to the image of 
the ﬁ  rst probe (image A). Before analysis, images were corrected for these 
pixel shifts as follows: The spatial correlation for pixels in which the gray 
value in both image A and B is >0 were analyzed with the Pearson’s 
  correlation coefﬁ  cient. Then, image B was moved one pixel to the left, and 
the correlation was recalculated. If a misalignment in ﬁ  lter resulted in a 
pixel shift to the right, image B that is moved one pixel to the left will have 
a higher spatial correlation with image A then the non-moved image B. 
If this was true, image B was moved permanently. The correlation was calcu-
lated for a move of image B to the left, right, up, or down. This procedure 
was repeated iteratively until the coefﬁ  cient no longer increased.
Online supplemental material
Figure S1 explains the PIP2 FRET assay. Figure S2 shows the speciﬁ  city of 
PIP2 antibodies used in this study. Figure S3 explains why the Pearson’s 
correlation coefﬁ  cient is insensitive to relative changes in images. Figure 
S4 shows coﬁ  lin membrane FRET controls. Figure S5 explains the loss of 
PIP2 upon rapamycin addition. Video 1 shows the lamellipod increase 
upon rapamycin treatment. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200706206/DC1.
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